Society guideline links: IgG4-related disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Chronic pancreatitis and pancreatic exocrine insufficiency".)

International

●International consensus guidance statement on the management and treatment of IgG4-related disease (2015)

●Consensus statement on the pathology of IgG4-related disease (2012)

United States

●American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR): Classification criteria for IgG4-related disease (2020)

Europe

●American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR): Classification criteria for IgG4-related disease (2020)

●United European Gastroenterology (UEG) and Swedish Society of Gastroenterology (SGF): European guideline on IgG4-related digestive disease – Evidence-based recommendations (2020)

Japan

●[In English] Japan Endocrine Society (JES): Clinical guidelines for the diagnosis and treatment of autoimmune and IgG4-related hypophysitis (2020)

●[In English] Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS): Clinical practice guidelines for IgG4-related sclerosing cholangitis (2019)

●[In Japanese] JSHBPS: Clinical practice guidelines for IgG4-related sclerosing cholangitis (2019)

●[In Japanese] Japanese Society of Nephrology (JSN): Diagnostic guideline for IgG4-related kidney disease (2011)